FDA
approval
· 2022-02-10
FDA Approved: NORTREL 21 DAY — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
Summary
The FDA approved Teva's supplemental application for Nortrel 21 Day, a generic combination oral contraceptive containing norethindrone and ethinyl estradiol.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for NORTREL 21 DAY (NORETHINDRONE AND ETHINYL ESTRADIOL)